NCT00895804View on ClinicalTrials.gov

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Mood DisorderSubstance-Related DisordersAmphetamine-Related Disorders
Interventions
DRUG

MDMA

capsule, 1.6 mg/kg body weight, single dose

DRUG

Pindolol

capsule of 20mg pindolol, single dose 1h before MDMA

Trial Locations (1)

8032

Heffter Research Center, University Hospital of Psychiatry, Zurich

Sponsors
All Listed Sponsors
collaborator

Heffter Research Institute

OTHER

lead

University Hospital, Basel, Switzerland

OTHER